Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Stephen J. Schuster, M.D.

Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research
Attending Physician, Department of Medicine, Division of Hematology-Oncology, Hospital of the University of Pennsylvania
Director, Lymphoma Translational Research, Abramson Cancer Center of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-157
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 614-1846
Fax: 215-615-5888
B.S. (Psychology)
Saint Joseph's University, Philadelphia, PA, 1976.

Laboratory Research Technician, Division of Rheumatology, Hahnemann Medical College and Hospital, Philadelphia, PA, 1977.
Jefferson Medical College, Philadelphia, PA, 1981.
Post-Graduate Training
Medical Internship, Pennsylvania Hospital, Philadelphia, PA., 1981-1982.
Resident in Medicine, Pennsylvania Hospital, Philadelphia, PA, 1982-1984.
Cardeza Clinical and Research Fellow in Medicine (Hematology), Jefferson Medical College, Philadelphia, PA, 1984-1988.
Postdoctoral Research Fellowship (NIH Sponsored Individual NRSA), Cardeza Foundation for Hematologic Research, Jefferson Medical College, Philadelphia, PA, 1986-1988.
Medical Oncology Fellowship, Pennsylvania Hospital, Philadelphia, PA, 1988-1989.
Diplomate, National Board of Medical Examiners, 1982.
Diplomate, American Board of Internal Medicine, 1984.
Diplomate, American Board of Hematology, 1986.
Diplomate, American Board of Medical Oncology, 1989.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Bair, Steven M. Strelec, Lauren. Nagle, Sarah J. Nasta, Sunita D. Landsburg, Daniel J. Mato, Anthony R. Loren, Alison W. Schuster, Stephen J. Stadtmauer, Edward A. Svoboda, Jakub.: Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis. American Journal of Hematology. May 16 2017 Notes: [Epub ahead of print]

Salles, Gilles. Schuster, Stephen J. de Vos, Sven. Wagner-Johnston, Nina D. Viardot, Andreas. Blum, Kristie A. Flowers, Christopher R. Jurczak, Wojciech J. Flinn, Ian W. Kahl, Brad S. Martin, Peter. Kim, Yeonhee. Shreay, Sanatan. Will, Matthias. Sorensen, Bess. Breuleux, Madlaina. Zinzani, Pier Luigi. Gopal, Ajay K.: Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study. Haematologica. 102(4), Apr 2017.

Jones, Jeffrey A. Hillmen, Peter. Coutre, Steven. Tam, Constantine. Furman, Richard R. Barr, Paul M. Schuster, Stephen J. Kipps, Thomas J. Flinn, Ian W. Jaeger, Ulrich. Burger, Jan A. Cheng, Mei. Ninomoto, Joi. James, Danelle F. Byrd, John C. O'Brien, Susan M. : Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib. British Journal of Haematology. Apr 10 2017 Notes: [Epub ahead of print]

Mato, Anthony R. Timlin, Colleen. Ujjani, Chaitra. Skarbnik, Alan. Howlett, Christina. Banerjee, Rahul. Nabhan, Chadi. Schuster, Stephen J.: Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study. British Journal of Haematology. Feb 21 2017 Notes: [Epub ahead of print]

Chong, Elise A. Melenhorst, J Joseph. Lacey, Simon F. Ambrose, David E. Gonzalez, Vanessa. Levine, Bruce. June, Carl H. Schuster, Stephen J. : PD-1 Blockade Modulates Chimeric Antigen Receptor (CAR) Modified T Cells and Induces Tumor Regression: Refueling the CAR. Blood. 129(8), Feb 23 2017.

Mato, Anthony R. Nabhan, Chadi. Barr, Paul M. Ujjani, Chaitra S. Hill, Brian T. Lamanna, Nicole. Skarbnik, Alan P. Howlett, Christina. Pu, Jeffrey J. Sehgal, Alison R. Strelec, Lauren E. Vandegrift, Alexandra. Fitzpatrick, Danielle M. Zent, Clive S. Feldman, Tatyana. Goy, Andre. Claxton, David F. Bachow, Spencer Henick. Kaur, Gurbakhash. Svoboda, Jakub. Nasta, Sunita Dwivedy. Porter, David. Landsburg, Daniel J. Schuster, Stephen J. Cheson, Bruce D. Kiselev, Pavel. Evens,Andrew M.: Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience. Blood. 128(18): 2199-2205, Nov 3 2016.

Wang, Jie. Morrissette, Jennifer. Lieberman, David B. Timlin, Colleen. Schuster, Stephen J. Mato, Anthony R.: Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia. British Journal of Haematology. Oct 7 2016 Notes: [Epub ahead of print]

Lesokhin, Alexander M. Ansell, Stephen M. Armand, Philippe. Scott, Emma C. Halwani, Ahmad. Gutierrez, Martin. Millenson, Michael M. Cohen, Adam D. Schuster, Stephen J. Lebovic, Daniel. Dhodapkar, Madhav. Avigan, David. Chapuy, Bjoern. Ligon, Azra H. Freeman, Gordon J. Rodig, Scott J. Cattry, Deepika. Zhu, Lili. Grosso, Joseph F. Bradley Garelik, M Brigid. Shipp, Margaret A. Borrello, Ivan. Timmerman, John.: Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study. Journal of Clinical Oncology. 34(23): 2698-704, Aug 10 2016.

Yam, Clinton. Landsburg, Daniel J. Nead, Kevin T. Lin, Xinyi. Mato, Anthony R. Svoboda, Jakub. Loren, Alison W. Frey, Noelle V. Stadtmauer, Edward A. Porter, David L. Schuster, Stephen J. Nasta, Sunita D.: Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas. American Journal of Hematology. 91(7): 672-6, Jul 2016.

Bhoj, Vijay G. Arhontoulis, Dimitrios. Wertheim, Gerald. Capobianchi, James. Callahan, Colleen A. Ellebrecht, Christoph T. Obstfeld, Amrom E. Lacey, Simon F. Melenhorst, Jan J. Nazimuddin, Farzana. Hwang, Wei-Ting. Maude, Shannon L. Wasik, Mariusz A. Bagg, Adam. Schuster, Stephen J. Feldman, Michael D. Porter, David L. Grupp, Stephen A. June, Carl H. Milone, Michael C.: Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy. Blood. 128(3), Jul 21 2016.

back to top
Last updated: 06/09/2017
The Trustees of the University of Pennsylvania
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration